CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 21208136)

Published in Expert Opin Ther Targets on January 06, 2011

Authors

Federica Borghese1, Felix I L Clanchy

Author Affiliations

1: Sapienza University of Rome, Department of Clinical Medicine, Clinical Immunology Unit, Umberto I Policlinico di Roma, 155 Viale del Policlinico, Rome, IT 00161.

Articles citing this

A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance. J Autoimmun (2012) 1.10

Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS. J Proteome Res (2013) 1.03

The role of macrophage migration inhibitory factor in autoimmune liver disease. Hepatology (2013) 0.95

Loss of CD73-mediated actin polymerization promotes endometrial tumor progression. J Clin Invest (2015) 0.94

Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis. Front Immunol (2013) 0.94

Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors. J Immunol (2015) 0.91

Innate immunity and cell death in alcoholic liver disease: role of cytochrome P4502E1. Redox Biol (2014) 0.91

CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer. World J Gastroenterol (2012) 0.88

A multi-targeted approach to suppress tumor-promoting inflammation. Semin Cancer Biol (2015) 0.87

Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass. J Bone Miner Res (2013) 0.85

Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection. Arthritis Rheum (2013) 0.82

Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients. Transplant Res (2012) 0.81

Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis. FASEB J (2014) 0.81

Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clin Cancer Res (2012) 0.81

Activated RET and ROS: two new driver mutations in lung adenocarcinoma. Transl Lung Cancer Res (2013) 0.81

CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74-dependent manner. Oncotarget (2015) 0.81

Stromal-dependent tumor promotion by MIF family members. Cell Signal (2014) 0.81

MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities. Front Immunol (2015) 0.79

Hippocampal gene expression meta-analysis identifies aging and age-associated spatial learning impairment (ASLI) genes and pathways. PLoS One (2013) 0.79

Network analysis of gene lists for finding reproducible prognostic breast cancer gene signatures. Bioinformation (2012) 0.79

Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer. BMC Cancer (2015) 0.78

Molecular basis for impaired collateral artery growth in the spontaneously hypertensive rat: insight from microarray analysis. Physiol Rep (2013) 0.77

MIF and autophagy: a novel link beyond "eating". Cell Res (2012) 0.77

Proton irradiation impacts age-driven modulations of cancer progression influenced by immune system transcriptome modifications from splenic tissue. J Radiat Res (2015) 0.77

Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas. Leuk Lymphoma (2015) 0.77

CD74 and intratumoral immune response in breast cancer. Oncotarget (2017) 0.77

Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses. Oncotarget (2016) 0.76

Transcriptome analysis of epigenetically modulated genome indicates signature genes in manifestation of type 1 diabetes and its prevention in NOD mice. PLoS One (2013) 0.76

Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma. Clin Cancer Res (2016) 0.76

CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice. J Immunol (2017) 0.75

CD74 in Kidney Disease. Front Immunol (2015) 0.75

Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancer. BMC Cancer (2017) 0.75

Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma. Oncotarget (2016) 0.75

Immunotherapy for B-Cell Neoplasms using T Cells expressing Chimeric Antigen Receptors: From antigen choice to clinical implementation. Sultan Qaboos Univ Med J (2012) 0.75

Relationship between elevated soluble CD74 and severity of experimental and clinical ALI/ARDS. Sci Rep (2016) 0.75